InBody Co

InBody Co EBIT Growth

The Year-over-Year EBIT Growth of InBody Co (041830.KQ) as of Oct 16, 2026 is 0.04 %. In the previous year, Year-over-Year EBIT Growth was -4.20 % — a change of -100.90% (higher).

EBIT Growth

0.04 %

YoY

-100.90%

Last updated:

Year-over-Year EBIT Growth of InBody Co is 2025 0.04 % . Year-over-Year EBIT Growth of InBody Co was 2024 -4.20 % . It decreases by -100.90% higher compared to the previous year.

The InBody Co EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
-4.91 KRW
Jan 1, 2019
15.84 KRW
Jan 1, 2020
-30.37 KRW
Jan 1, 2021
87.74 KRW
Jan 1, 2022
13.52 KRW
Jan 1, 2023
-5.77 KRW
Jan 1, 2024
-4.20 KRW
Jan 1, 2025
0.04 KRW
The InBody Co EBIT Growth history
YEAREBIT GrowthYoY
0.04 %-100.90%
-4.20 %-27.29%
-5.77 %-142.71%
13.52 %-84.59%
87.74 %-388.87%
-30.37 %-291.75%
15.84 %-422.38%
-4.91 %-135.14%
13.98 %+52.14%
9.19 %-90.64%
98.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Stock analysis

What does InBody Co do? InBody Co Ltd is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company went public on December 14, 2000, as indicated by its IPO date. InBody Co Ltd focuses on the manufacturing and sale of medical equipment, specifically body composition analyzers. The company markets its products under the brand names InBody and Lookin’Body. Among its InBody series, products include the InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10. The Lookin’Body series features models such as Lookin’Body3.0 and Lookin’Body Basic, designed for measuring various body composition metrics including proteins, minerals, fats, and moisture. The company also offers BMI measuring devices under the brand BSM. InBody Co Ltd serves both domestic and international markets with its product range. The company's website is https://www.inbody.co.kr/. The description provided includes redundant references to the company's product lines and brand names, but the core facts about its operations, headquarters, and product categories are consistent. No additional details about founding year, key personnel, acquisitions, or financial figures are included in the source material, so these elements are omitted from the profile. InBody Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBody Co stock

Year-over-Year EBIT Growth of InBody Co is 0.04 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth InBody Co since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's InBody Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — InBody Co

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — InBody Co